Lista de obras -

A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin

artículo científico publicado en 2017

A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes

artículo científico publicado en 2019

Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia

artículo científico publicado en 2007

Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.

artículo científico

Association between duodenal contents reflux and squamous cell carcinoma--establishment of an esophageal cancer cell line derived from the metastatic tumor in a rat reflux model.

artículo científico publicado en 2007

BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma

scientific article published on 01 April 2020

BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy

artículo científico publicado en 2020

Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography

artículo científico publicado en 2019

Brain metastasis-related microRNAs in patients with advanced breast cancer

artículo científico publicado en 2019

Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis

scientific article published in 2022

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)

scientific article published on 02 January 2021

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanes

artículo científico publicado en 2019

Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan

artículo científico publicado en 2017

Dose exploration results from Phase 1 study of cemiplimab, a human monoclonal programmed death (PD)-1 antibody, in Japanese patients with advanced malignancies

artículo científico publicado en 2020

Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis.

artículo científico publicado en 2017

Efficacy and Safety of Pazopanib for Recurrent or Metastatic Solitary Fibrous Tumor.

artículo científico publicado en 2018

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

artículo científico publicado en 2017

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study

artículo científico publicado en 2018

Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study

article

Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer.

artículo científico publicado en 2016

Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy

artículo científico publicado en 2017

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors

artículo científico publicado en 2019

First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors

artículo científico publicado en 2020

Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy

scientific article published on 02 August 2019

Gene aberration profile of tumors of adolescent and young adult females.

artículo científico publicado en 2017

Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression

artículo científico publicado en 2019

HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix

scientific article published on 23 July 2020

High-throughput functional evaluation of BRCA2 variants of unknown significance

scientific article published on 22 May 2020

Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults

artículo científico publicado en 2016

Improved survival among patients enrolled in oncology phase 1 trials in recent decades

scientific article published on 19 November 2019

Induction of gastric GIST in rat and establishment of GIST cell line

artículo científico publicado en 2006

Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trials

artículo científico publicado en 2020

LC-MS bioanalysis of Trastuzumab and released emtansine using nano-surface and molecular-orientation limited (nSMOL) proteolysis and liquid-liquid partition in plasma of Trastuzumab emtansine-treated breast cancer patients.

artículo científico publicado en 2017

Long Non-coding NR2F1-AS1 is Associated with Tumor Recurrence in Estrogen Receptor-positive breast cancers

scientific article published on 11 May 2020

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer

scientific article published on 05 March 2020

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer

artículo científico publicado en 2020

Novel combination of serum microRNA for detecting breast cancer in the early stage.

artículo científico publicado en 2016

PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system

scientific article published on 28 July 2018

Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.

artículo científico publicado en 2017

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.

artículo científico publicado en 2014

Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs

artículo científico publicado en 2020

Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer.

artículo científico publicado en 2016

Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer.

artículo científico publicado en 2018

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours

artículo científico publicado en 2019

Pitfalls in the detection of t(11;22) translocation by fluorescence in situ hybridization and RT-PCR: a single-blinded study

artículo científico publicado en 2006

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site

artículo científico publicado en 2018

Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy

artículo científico publicado en 2017

Radiation-induced esophagitis exacerbated by everolimus

artículo científico publicado en 2013

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

artículo científico publicado en 2020

Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation

scientific article published on 06 March 2020

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study

artículo científico publicado en 2017

Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

scientific article published on 27 November 2018

Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer

artículo científico publicado en 2019

Suggestions Regarding the GEICAM/2003-11_CIBOMA/2004-01 Trial: Future Treatment Options for Early Triple-Negative Breast Cancer

artículo científico publicado en 2020

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment

artículo científico publicado en 2020

Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer.

artículo científico publicado en 2018

TERT promoter hotspot mutations in breast cancer.

artículo científico publicado en 2017

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients

scientific article published on 16 April 2020

The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site

scientific article published on 01 February 2019

The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma

artículo científico publicado en 2017

The Use of PET/CT and Bone Marrow Aspiration/Biopsy in Initial Staging Evaluation of Adolescent and Adult Ewing Sarcomas

artículo científico publicado en 2017

The safety of chemotherapy for breast cancer patients with hepatitis C virus infection

scientific article published on 24 July 2013

The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection

artículo científico publicado en 2014

Thioproline prevents carcinogenesis in the remnant stomach induced by duodenal reflux

artículo científico publicado en 2005

Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma

artículo científico publicado en 2020

Tremelimumab-associated tumor regression following after initial progression: two case reports

artículo científico publicado en 2015

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer.

artículo científico publicado en 2017

Visualization of HER2-specific breast cancer intratumoral heterogeneity using 64Cu-DOTA-trastuzumab PET.

artículo científico publicado en 2017

[Ifosfamide and Paclitaxel for Recurrent or Metastatic Uterine Carcinosarcoma]

scientific article published on 01 October 2019

[Ⅰ.Detecting Early Breast Cancer by Serum MicroRNA]

scientific article published on 01 December 2019

＜Editors' Choice＞ Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group.

artículo científico publicado en 2018

Lista de obras de

A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin

A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes

Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia

Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.

Association between duodenal contents reflux and squamous cell carcinoma--establishment of an esophageal cancer cell line derived from the metastatic tumor in a rat reflux model.

BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma

BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy

Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography

Brain metastasis-related microRNAs in patients with advanced breast cancer

Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)

Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanes

Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan

Dose exploration results from Phase 1 study of cemiplimab, a human monoclonal programmed death (PD)-1 antibody, in Japanese patients with advanced malignancies

Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis.

Efficacy and Safety of Pazopanib for Recurrent or Metastatic Solitary Fibrous Tumor.

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study

Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study

Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer.

Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors

First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors

Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy

Gene aberration profile of tumors of adolescent and young adult females.

Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression

HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix

High-throughput functional evaluation of BRCA2 variants of unknown significance

Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults

Improved survival among patients enrolled in oncology phase 1 trials in recent decades

Induction of gastric GIST in rat and establishment of GIST cell line

Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trials

LC-MS bioanalysis of Trastuzumab and released emtansine using nano-surface and molecular-orientation limited (nSMOL) proteolysis and liquid-liquid partition in plasma of Trastuzumab emtansine-treated breast cancer patients.

Long Non-coding NR2F1-AS1 is Associated with Tumor Recurrence in Estrogen Receptor-positive breast cancers

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer

Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer

Novel combination of serum microRNA for detecting breast cancer in the early stage.

PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system

Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.

Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs

Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer.

Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer.

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours

Pitfalls in the detection of t(11;22) translocation by fluorescence in situ hybridization and RT-PCR: a single-blinded study

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site

Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy

Radiation-induced esophagitis exacerbated by everolimus

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study

Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer

Suggestions Regarding the GEICAM/2003-11_CIBOMA/2004-01 Trial: Future Treatment Options for Early Triple-Negative Breast Cancer

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment

Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer.

TERT promoter hotspot mutations in breast cancer.

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients

The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site

The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma

The Use of PET/CT and Bone Marrow Aspiration/Biopsy in Initial Staging Evaluation of Adolescent and Adult Ewing Sarcomas

The safety of chemotherapy for breast cancer patients with hepatitis C virus infection

The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection

Thioproline prevents carcinogenesis in the remnant stomach induced by duodenal reflux

Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma

Tremelimumab-associated tumor regression following after initial progression: two case reports

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer.

Visualization of HER2-specific breast cancer intratumoral heterogeneity using 64Cu-DOTA-trastuzumab PET.

[Ifosfamide and Paclitaxel for Recurrent or Metastatic Uterine Carcinosarcoma]

[Ⅰ.Detecting Early Breast Cancer by Serum MicroRNA]

＜Editors' Choice＞ Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group.